Showing 15,181 - 15,200 results of 31,914 for search '(( 50 ((((ns decrease) OR (we decrease))) OR (a decrease)) ) OR ( e point decrease ))', query time: 0.96s Refine Results
  1. 15181
  2. 15182

    Table 1_A study on the effects of modified sprint interval trainingon physical fitness test scores and the quantitative and dose-response relationships among Chinese male universit... by Guoyuan Huang (4262416)

    Published 2025
    “…Additionally, The results of the physical fitness test showed significant improvements: standing long jump (SLJ) increased from 2.31 ± 0.15 m to 2.45 ± 0.18 m (significance level p < 0.01), 50 m sprint time decreased from 7.32 ± 0.42 s to 6.98 ± 0.38 s (significance level p < 0.01), and 1,000 m from 235.6 ± 18.4 s to 220.3 ± 16.8 s (significance level p < 0.01). …”
  3. 15183

    DataSheet1_Sodium Tanshinone IIA Sulfonate as a Potent IDO1/TDO2 Dual Inhibitor Enhances Anti-PD1 Therapy for Colorectal Cancer in Mice.pdf by Rongjie Zhang (5625083)

    Published 2022
    “…Here, we discovered that sodium tanshinone IIA sulfonate (STS), a sulfonate derived from tanshinone IIA (TSN), reduced the enzymatic activities of IDO1 and TDO2 with a half inhibitory concentration (IC<sub>50</sub>) of less than 10 μM using enzymatic assays for natural product screening. …”
  4. 15184
  5. 15185
  6. 15186
  7. 15187
  8. 15188

    Data_Sheet_1_Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head a... by Sati Akbaba (7213499)

    Published 2019
    “…While bimodal RT for ITAC resulted in a significantly decreased 3-year LC rate of 50 vs. 93% for each SGAC and SDAC (p < 0.01), no statistical significant survival differences could be identified across the three groups regarding OS (p = 0.08) and PFS (p = 0.063). 3-year OS was 88% for SGAC, 78% for SDAC and 67% for ITAC and 3-year PFS was 72% for SGAC, 53% for SDAC and 44% for ITAC, respectively. …”
  9. 15189

    Data_Sheet_2_Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head a... by Sati Akbaba (7213499)

    Published 2019
    “…While bimodal RT for ITAC resulted in a significantly decreased 3-year LC rate of 50 vs. 93% for each SGAC and SDAC (p < 0.01), no statistical significant survival differences could be identified across the three groups regarding OS (p = 0.08) and PFS (p = 0.063). 3-year OS was 88% for SGAC, 78% for SDAC and 67% for ITAC and 3-year PFS was 72% for SGAC, 53% for SDAC and 44% for ITAC, respectively. …”
  10. 15190
  11. 15191

    Neuronal responses to visual stimuli in the proposed microcircuit model with different excitatory/inhibitory (E/I) ratios caused by a change in pyramidal (Pyr) neuron and somatosta... by Nobuhiko Wagatsuma (494052)

    Published 2025
    “…<p>As in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1013306#pcbi.1013306.g003" target="_blank">Fig 3</a>, the total number of model neurons in the network remained consistent, irrespective of E/I ratio. …”
  12. 15192

    DataSheet_1_Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma.pdf by Paul D. Bates (7178726)

    Published 2021
    “…<p>Management for high-risk neuroblastoma (NBL) has included autologous hematopoietic stem cell transplant (HSCT) and anti-GD2 immunotherapy, but survival remains around 50%. The aim of this study was to determine if allogeneic HSCT could serve as a platform for inducing a graft-versus-tumor (GVT) effect against NBL with combination immunocytokine and NK cells in a murine model. …”
  13. 15193
  14. 15194

    DataSheet_1_Dynamic Change of Thyroid Hormones With Postmenstrual Age in Very Preterm Infants Born With Gestational Age <32 Weeks: A Multicenter Prospective Cohort Study.pdf by Ranran Shi (10498970)

    Published 2021
    “…The results prompt that age-related cutoffs, instead of a single reference range, might be more useful to explain the thyroid function of VPIs. …”
  15. 15195

    DataSheet_1_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.doc by Mengting Chen (1419172)

    Published 2023
    “…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”
  16. 15196
  17. 15197
  18. 15198
  19. 15199
  20. 15200